Che‐Yuan Wu

Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study

Che‐Yuan Wu, Carina Iskander, Christa Wang et al. · Diabetes Care · 2022 · 131 citations · Full text

Medicine, Geriatric Medicine, Pharmacology +17

Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role <i>APOE</i> carrier status

Che‐Yuan Wu, Michael Ouk, Yuen Yan Wong et al. · Alzheimer s & Dementia · 2020 · 93 citations · Full text

Medicine, Neurology, Pharmacology +14

Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease

Zahra Shirzadi, Stephanie A. Schultz, Wai‐Ying Wendy Yau et al. · JAMA Neurology · 2023 · 87 citations · Full text

Medicine, Neurology, Neuroscience +17

The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status

Michael Ouk, Che‐Yuan Wu, Jennifer S. Rabin et al. · Alzheimer s Research & Therapy · 2021 · 69 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease

Kritleen K. Bawa, Saffire H. Krance, Nathan Herrmann et al. · Journal of Neuroinflammation · 2020 · 67 citations · Full text

Life Sciences, Neurology, Neuroscience +17